Amela Petty
Medical · Austin, TXNPI 1922344043
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,967 of the $15,680 with a category attached, or 89.1%. 30 manufacturers reported payments, led by Abbott at 39.7% of the total. Reporting peaked in 2022 at $5,764 and has fallen 59.9% since, to $2,312 in 2025. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 806 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Relievant Medsystems, Inc.$2K
- Spinal Simplicity, LLC$1K
- Collegium Pharmaceutical, Inc.$759
- AbbVie$582
- Protega Pharmaceutials Inc$467
- plus $4K from 24 others
What the payments were for
- Travel & lodging$1,71311%
- Food & beverage$13,96789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 450 | $6,221 |
| Relievant Medsystems, Inc. | 21 | $2,462 |
| Spinal Simplicity, LLC | 46 | $1,373 |
| Collegium Pharmaceutical, Inc. | 39 | $759 |
| AbbVie | 31 | $582 |
| Protega Pharmaceutials Inc | 27 | $467 |
| Boston Scientific | 11 | $456 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $405 |
| Medtronic | 15 | $337 |
| Pfizer | 19 | $320 |
| IBSA Pharma Inc. | 19 | $307 |
| Si-bone, Inc. | 10 | $252 |
| Averitas Pharma Inc. | 7 | $246 |
| Biohaven Pharmaceutical Holding Company Ltd. | 22 | $233 |
| SPR Therapeutics, Inc | 4 | $213 |
| Amgen(2 entities) | 11 | $211 |
| Almatica Pharma LLC | 9 | $156 |
| Biohaven Pharmaceuticals, Inc. | 13 | $129 |
| Lilly USA, LLC | 6 | $90 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| Nalu Medical, Inc. | 5 | $85 |
| Redhill Biopharma Inc. | 4 | $73 |
| Vertex | 2 | $46 |
| Emergent Biosolutions Inc. | 1 | $45 |
| Valinor Pharma, LLC | 2 | $42 |
| Foundation Fusion Solutions, LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Hydrocision, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,796
- PROCLAIM$1,203
- HA MINUTEMAN G3-R$637
- ETERNA$509
- Proclaim IPG$296
- INTELLIS ADAPTIVESTIM$143
- Qutenza$127
- UBRELVY$124
- SUPERION$115
- SPRINT PNS System$106
How this compares
$15,680 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 29 | $22,978 |
| MovantikNaloxegol Oxalate | 27 | $13,237 |
| Buprenorphine | 18 | $5,459 |
| Pregabalin | 200 | $5,104 |
| Gabapentin | 368 | $4,865 |
| Lidocaine | 22 | $3,282 |
| Diclofenac Sodium | 73 | $2,871 |
| Tramadol Hcl | 281 | $2,006 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 90 | $1,620 |
| Naloxone Hcl | 25 | $1,394 |
| Methocarbamol | 69 | $1,236 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 40 | $1,006 |
| Tizanidine Hcl | 77 | $991 |
| Duloxetine Hcl | 49 | $852 |
| Cyclobenzaprine Hcl | 99 | $841 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $759 | $22,97829 claims |
| Redhill Biopharma Inc.Movantik | $73 | $13,23727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,490 medical providers in Texas.
Other medical in Austin
- Isabell BacotAustin$65K
- Lindsay ReckAustin$18K
- Jeri BelyeaAustin$14K
- Mikel ZamoraAustin$13K
- Theresa ManriquezAustin$13K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.